AnatomyDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsTechnology, Industry, AgricultureInformation Science
Leukemia, Megakaryoblastic, AcuteMegakaryocytesDown SyndromeMegakaryocyte Progenitor CellsGATA1 Transcription FactorChromosomes, Human, Pair 21Primary MyelofibrosisOncogene Proteins, FusionKaryotypingLeukemiaHistocytochemistryLeukemia, Myeloid, AcuteBone MarrowCell DifferentiationAcute DiseaseTumor Cells, CulturedLeukemia, Lymphocytic, Chronic, B-CellLeukemia, LymphoidBlast InjuriesLeukemia, ExperimentalLeukemia, Myelogenous, Chronic, BCR-ABL PositiveEncyclopedias as TopicGATA4 Transcription FactorHemoglobinsGATA6 Transcription FactorBlood SubstitutesGATA2 Transcription FactorErythrocytes
Monocytic leukemiaMixed-phenotype acute leukemiaDifferentiationNeoplasmsPromyelocyticChronicLineageProliferations related to Down syndromeMyelodysplastic syndromePediatric acute myeloidMaturationPanmyelosis with myelofibrosisSarcomaMyelofibrosisMyelogenousAbnormalSubtypesGranulocyticLeukaemiaMutationLymphoblasticPeripheralMarrowMegakaryocytic LeukemiaLeukemicAMKLMalignanciesTransientSyndromeImmatureStemLymphocyticMorphologicEosinophils
Monocytic leukemia2
  • Patients with acute monoblastic and monocytic leukemia may present with bleeding disorders, as well as with extramedullary masses, cutaneous and gingival infiltration, and central nervous system involvement. (medscape.com)
  • Patients with acute monocytic leukemia also have a high incidence of clinically significant DIC. (medscape.com)
Mixed-phenotype acute leukemia1
Differentiation4
  • Patients with acute myeloid leukemia (AML) with minimal differentiation, AML without differentiation, and AML with differentiation usually present with evidence of bone marrow failure (ie, anemia , neutropenia , and/or thrombocytopenia ). (medscape.com)
  • In line with this, we observed myeloid differentiation upon visual inspection (Supplementary Fig. 3A ) and upregulation of the myeloid markers CD86 and CD11b after 3 days of LSD1 inhibitor treatment (Supplementary Fig. 3B ). (nature.com)
  • AML-M0, acute myeloblastic leukemia with minimal differentiation , ALL, acute lymphoblastic leukemia/lymphoblastic lymphoma. (atlasgeneticsoncology.org)
  • The natural process of blood cell formation, hematopoietic stem cell differentiation, and generation of myeloid and lymphoid cell lineages. (oncomine.com)
Neoplasms9
  • Acute myeloid leukemia (AML) and related neoplasms. (oncolink.org)
  • Therapy-related myeloid neoplasms. (oncolink.org)
  • Myeloid neoplasms with germline predisposition without a preexisting disorder or organ dysfunction. (oncolink.org)
  • Myeloid neoplasms with germline DDX41 mutation. (oncolink.org)
  • Myeloid neoplasms with germline predisposition and preexisting platelet disorders. (oncolink.org)
  • Myeloid neoplasms with germline predisposition and other organ dysfunction. (oncolink.org)
  • 5 Hematopoietic disruptions in the myeloid lineage can lead to 3 major disease categories: acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), and myelodysplastic syndrome (MDS). (oncomine.com)
  • Myeloproliferative neoplasms present with the clonal proliferation of 1 or more myeloid cell lineages.10 The role of genetic and genomic aberrations in pathogenesis has been well documented for these disorders. (oncomine.com)
  • Acute myeloid leukemia (AML) is a group of clonal hematopoietic neoplasms that are characterized by aberrations in maturation, proliferation, and survival in the stem and progenitor cell compartments. (biomedcentral.com)
Promyelocytic3
  • Acute Promyelocytic Leukemia. (lab-ally.com)
  • Cytogenetic studies performed on bone marrow provide important prognostic information and can guide treatment by confirming a diagnosis of acute promyelocytic leukemia (APL). (medscape.com)
  • Acute promyelocytic leukemia (APL), also known as M3, is the most common subtype of AML associated with DIC. (medscape.com)
Chronic6
  • 1,2 The 4 primary disorders of MPNs are chronic myeloid leukemia (CML), polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). (oncomine.com)
  • Characterized by excessive, abnormal white blood cell (granulocyte) production and the presence of the Philadelphia chromosome/BCR-ABL mutation, chronic myeloid leukemia (CML) is a slow-growing cancer of the blood-forming tissue (bone marrow). (oncomine.com)
  • Ophthalmic manifestations of leukemia are more frequent with acute than chronic leukemia and can affect all intraocular structures. (dovepress.com)
  • Symptoms may vary from chronic symptoms like retinopathy, CKD, hematopoietic ulcers to severe acute complaints like "Sickle Cell Crisis" triggered by dehydration, infections, acidosis and other obscure reasons. (atomictherapy.org)
  • Chronic myeloid leukemia ( CML ), BCR-ABL1-positive, is a myeloproliferative neoplasm (MPN) in which granulocyte s are the major proliferative component. (cancer.gov)
  • Acute lymphoblastic leukemia (ALL), Multiple myeloma (MM), and Chronic lymphocytic leukemia (CLL), and Diffuse Large B-Cell Lymphoma (DLBCL). (codemap.com)
Lineage2
  • Immunophenotyping is required to determine myeloid lineage. (medscape.com)
  • Acute leukemias of ambiguous lineage. (oncolink.org)
Proliferations related to Down syndrome2
  • In addition, it is also important to exclude other, more specific AML categories (ie, AML with myelodysplasia-related changes, therapy-related myeloid neoplasm, AML with germline predisposition, myeloid proliferations related to Down syndrome) before classifying a condition as AML NOS. (medscape.com)
  • Myeloid proliferations related to Down syndrome. (oncolink.org)
Myelodysplastic syndrome2
  • Cases with an erythroid predominance but less than 20% blasts among the total number of marrow cells are now classified as myelodysplastic syndrome (MDS). (medscape.com)
  • This is a multicenter, open-label, Phase 1/2a dose escalation and expansion study of orally administered emavusertib (CA-4948) monotherapy in adult patients with Acute Myelogenous Leukemia (AML) or high risk Myelodysplastic Syndrome (MDS). (rochester.edu)
Pediatric acute myeloid1
  • Accordingly, RNA-sequencing analysis of pediatric acute myeloid leukemia (AML) subtypes revealed that LSD1 was highly expressed in acute megakaryoblastic leukemia (AMKL), and especially in TAM and ML-DS patients (Supplementary Fig. 1 ). (nature.com)
Maturation1
  • Multiple blast cells and eosinophils in various stages of maturation. (oncohemakey.com)
Panmyelosis with myelofibrosis1
Sarcoma3
  • Myeloid sarcoma. (oncolink.org)
  • AML affects the ocular system through direct infiltration of tissues, secondary to hematological abnormalities, or in the form of chloroma or myeloid sarcoma in the brain or orbit consequently leading to a variety of manifestations depending on the ocular tissue involved. (dovepress.com)
  • Myeloid sarcoma, also known as chloroma, granulocytic sarcoma or myeloblastoma is a type of extramedullary myeloid tumor. (dovepress.com)
Myelofibrosis2
  • In this issue of Blood , Wagner-Ballon and colleagues provide new insights into the pathogenesis of myelofibrosis with myeloid metaplasia (MMM) and a targeted therapeutic approach of NF-κB inhibition with the proteosome inhibitor bortezomib. (ashpublications.org)
  • Malignant myelofibrosis (sometimes called acute myelofibrosis), is a rare variant of myelofibrosis characterized by pancytopenia, myeloblastosis, and marrow fibrosis that has a more rapidly progressive downhill course and is generally due to a type of acute leukemia called acute megakaryoblastic leukemia. (msdmanuals.com)
Myelogenous2
  • Acute myelogenous leukemia (AML) is a blood cancer that affects white blood cells, red blood cells, and/or platelets. (oncolink.org)
  • Role of signal transduction inhibition in treatment of acute myelogenous leukemia/myelodysplasia. (rochester.edu)
Abnormal5
  • An aggressive disease (rapid onset and progression) that occurs primarily in adulthood and is marked by an abnormal increase and accumulation of myeloblasts (immature myeloid cells) in the bone marrow and blood, which leads to impaired hematopoiesis and bone marrow failure. (oncomine.com)
  • Two blast cells, two neutrophilic cells with dumbbell nuclei (pseudo-Pelger cells) and an abnormal eosinophil with five-lobed nucleus. (oncohemakey.com)
  • Acute myeloid leukemia (AML) is a malignant disorder of the hematopoietic stem cells characterized by abnormal proliferation of myeloid blast cells in the bone marrow and blood, preventing them from further differentiating into the specialized cells of the bone marrow and thus causing pancytopenia. (dovepress.com)
  • A full blood picture (FBP) performed at 48 hours of life suggested Transient Abnormal Myelopoiesis (TAM) with a blast percentage of 42% as shown in Figure 1. (apjpch.com)
  • Children with Down syndrome (DS) are at increased risk of developing distinctive clonal myeloid disorders, including transient abnormal myelopoiesis (TAM) and myeloid leukaemia of DS (ML-DS). (smj.org.sg)
Subtypes1
  • This section briefly discusses the morphologic features of the subtypes of acute myeloid leukemia (AML) not otherwise categorized (NOS). (medscape.com)
Granulocytic1
Leukaemia2
  • DS is also characterised by an increased susceptibility to childhood leukaemia,( 2 - 4 ) including an increased frequency of distinctive clonal myeloid disorders in early childhood. (smj.org.sg)
  • 5 ) After a period of apparent remission (1-4 years), 20%-30% of DS children with TAM progress to develop a characteristic, treatment-responsive megakaryoblastic form of acute myeloid leukaemia termed myeloid leukaemia of DS (ML-DS). (smj.org.sg)
Mutation1
  • Leukemic blasts in transformed JAK2-V617F -positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation. (ashpublications.org)
Lymphoblastic4
  • B-Cell Acute Lymphoblastic Leukemia. (lab-ally.com)
  • Myeloid malignancies and acute lymphoblastic leukemia (ALL). (atlasgeneticsoncology.org)
  • Deletion of 7p as the sole abnormality occurs in disorders with myelodysplastic or myeloproliferative features and acute lymphoblastic leukemia, and may therefore affect early hematopoietic progenitor cells. (atlasgeneticsoncology.org)
  • Expression of the multidrug transporter P-glycoprotein is highly correlated with clinical outcome in childhood acute lymphoblastic leukemia: Results of a long-term prospective study. (ugent.be)
Peripheral3
  • Immunophenotyping by flow cytometry of bone marrow or peripheral blood samples can be used to help distinguish AML from acute lymphocytic leukemia (ALL) and further classify the subtype of AML. (medscape.com)
  • The diagnosis of TAM was based on observation of unequivocal blasts on peripheral blood microscopy. (smj.org.sg)
  • Peripheral blood smear shows blasts and schistocytes. (medbullets.com)
Marrow5
  • in the new classification system, blasts are always enumerated as a percentage of total marrow nucleated cells. (medscape.com)
  • Although patients with acute megakaryoblastic leukemia may present with evidence of bone marrow failure associated with pancytopenia, in some cases, thrombocytosis is present. (medscape.com)
  • Number of patients who achieved a Complete Response (CR) with Minimal Residual Disease (MRD), a Complete Response with incomplete hematologic recovery (CRi), or showed reduced blasts in their bone marrow by flow cytometry (Cytoreduction). (clincosm.com)
  • Remission is when there are less than 5% blast cells in the bone marrow. (oncolink.org)
  • 10,14 The eventual accumulation of immature white blood cells (myeloblasts or blasts) in the blood and bone marrow impairs other blood cell development and leads to a shortage of red blood cells (anemia) and platelets. (oncomine.com)
Megakaryocytic Leukemia1
Leukemic1
  • Note the unstained leukemic blast cell in bottom of field. (oncohemakey.com)
AMKL1
  • The combination of LSD1 inhibition and ruxolitinib proved to be very effective in non-DS-AMKL blasts, however, with only additive cytotoxic effects in one of the two patient samples (Fig. 1A ). (nature.com)
Malignancies5
  • 2015). 5 patients with myeloid malignancies had secondary disorders treated for a previous malignancy (Mecucci et al. (atlasgeneticsoncology.org)
  • Deletion of 7p, appears to confer increased risk of treatment failure and inferior outcome, same as it observed with monosomy 7 in myeloid malignancies. (atlasgeneticsoncology.org)
  • With an ever-growing list of biomarkers, inherent genetic complexity, and the risk of rapid progression, myeloid malignancies challenge the current iterative testing paradigm and call for a streamlined testing approach that yields rapid results. (oncomine.com)
  • 3 Results can be available within hours or days, depending on the platform.3 With its demonstrated clinical utility in myeloid malignancies, NGS is transforming the testing paradigm and enabling better outcomes for patients. (oncomine.com)
  • Myeloid malignancies arise from mutations in hematopoietic stem or progenitor cells. (oncomine.com)
Transient1
  • These diseases include transient myeloproliferative disorder occurring in Down syndrome, acute megakaryoblastic leukemia occurring in Down syndrome, Diamond-Blackfan anemia, and various combined anemia-thrombocytopenia syndromes including a gray platelet syndrome-type disorder. (wikipedia.org)
Syndrome2
Immature1
  • Blasts and immature basophils, the predominant blood cell types. (oncohemakey.com)
Stem2
  • Interestingly, chemotherapy, including hydroxyurea, has been associated with acute leukemia in JAK2 V617F-negative stem cells in some PV patients. (basicmedicalkey.com)
  • I have expertise in novel therapies for acute myeloid leukemia, stem cell mobilization and homing, as well as stem cell transplantation. (rochester.edu)
Lymphocytic2
Morphologic1
  • AML-M0 cannot be diagnosed on morphologic grounds alone, because the blasts are of varying size and are agranular, sometimes resembling lymphoblasts (see the image below). (medscape.com)
Eosinophils2
  • Frequent eosinophils with myeloid immaturity and blast cells (note prominent nucleoli). (oncohemakey.com)
  • The blast percentage, marked dysmorphia of eosinophils, and the patient's course was consistent with acute eosinophilic leukemia. (oncohemakey.com)